HemoCath

Indonesia
Tangkanpulit, West Nusa Tenggara, Indonesia

Company profile

HemoCath company profile

HemoCath is a US/Irish pre-revenue startup that has developed and is now commercializing the HemoCath™ PA catheter and the Luc™ HFM platform — offering the potential to improve clinical outcomes and reduce healthcare costs for people with heart failure (HF).

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2020-01-01, Year

Headquarters

Country code
ID
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Last funding
Pre Seed / 2020-04-01
Last equity funding
Pre Seed
Founders
4

Founders and investors

Founders

​Christopher GloverDes ReganEric CaronMichael Nagy